Shimuta Ken, Watanabe Yuko, Nakayama Shu-ichi, Morita-Ishihara Tomoko, Kuroki Toshiro, Unemo Magnus, Ohnishi Makoto
National Institute of Infectious Diseases, Tokyo, Japan.
Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan.
BMC Infect Dis. 2015 Sep 17;15:378. doi: 10.1186/s12879-015-1110-x.
Neisseria gonorrhoeae strains with resistance to extended-spectrum cephalosporins (ESCs), last options for first-line monotherapy of gonorrhoea, likely emerged and initially disseminated in Japan, followed by international transmission. In recent years, multi-locus sequence typing (MLST) ST1901 and N. gonorrhoeae multiantigen sequence typing (NG-MAST) ST1407 isolates with the mosaic penicillin-binding protein (PBP) 2 XXXIV have accounted for most ESC resistance globally. Our aim was to elucidate the initial emergence and transmission of ESC-resistant strains by detailed examination of N. gonorrhoeae isolates from 1995 to 2005 in Kanagawa, Japan.
N. gonorrhoeae isolates were examined phenotypically (n = 690) and genetically (n = 372) by agar dilution method (cefixime, ceftriaxone and ciprofloxacin), penA gene sequencing, MLST and NG-MAST.
Already in 1995, one cefixime-resistant (CFM-R) isolate was found, which is the first CFM-R isolate described globally. After 1996, the prevalence of CFM-R and CFM-decreased susceptibility (CFM-DS) isolates significantly increased, with the peak resistance level in 2002 (57.1% CFM-R). In 1997-2002, the CFM-R MLST ST7363 strain type with the mosaic PBP 2 X was predominant among CFM-R/DS isolates. The first CFM-R/DS MLST ST1901 clone(s), which became the predominant CFM-R/DS strain type(s) already in 2003-2005, possessed the mosaic PBP 2 X, which was possibly originally transferred from the MLST ST7363 strains, and subsequently acquired the mosaic PBP 2 XXXIV. The first MLST ST1901 and NG-MAST ST1407 isolate was identified in Kanagawa already in 2003.
The two main internationally spread cefixime-resistant gonococcal clones, MLST ST7363 and ST1901 (NG-MAST ST1407 most frequent internationally) that also have shown their capacity to develop high-level ceftriaxone resistance (superbugs H041 and F89), likely emerged, evolved and started to disseminate in the metropolitan area, including Kanagawa, in Japan, which was followed by global transmission.
对超广谱头孢菌素(ESCs)耐药的淋病奈瑟菌菌株,作为淋病一线单药治疗的最后选择,可能最早在日本出现并初步传播,随后在国际间传播。近年来,具有嵌合青霉素结合蛋白(PBP)2 XXXIV的多位点序列分型(MLST)ST1901和淋病奈瑟菌多抗原序列分型(NG-MAST)ST1407分离株在全球范围内导致了大多数对ESCs的耐药性。我们的目的是通过详细检测1995年至2005年日本神奈川县的淋病奈瑟菌分离株,来阐明对ESCs耐药菌株的最初出现和传播情况。
采用琼脂稀释法(头孢克肟、头孢曲松和环丙沙星)、penA基因测序、MLST和NG-MAST对淋病奈瑟菌分离株进行表型(n = 690)和基因(n = 372)检测。
早在1995年就发现了一株对头孢克肟耐药(CFM-R)的分离株,这是全球报道的首例CFM-R分离株。1996年后,CFM-R和CFM-敏感性降低(CFM-DS)分离株的流行率显著增加,2002年耐药水平达到峰值(57.1% CFM-R)。1997年至2002年,具有嵌合PBP 2 X的CFM-R MLST ST7363菌株类型在CFM-R/DS分离株中占主导地位。最早的CFM-R/DS MLST ST1901克隆株在2003年至2005年已成为主要的CFM-R/DS菌株类型,其具有嵌合PBP 2 X,可能最初是从MLST ST7363菌株转移而来,随后又获得了嵌合PBP 2 XXXIV。最早的MLST ST1901和NG-MAST ST1407分离株于2003年在神奈川县被鉴定出来。
两种主要在国际上传播的对头孢克肟耐药的淋球菌克隆株,MLST ST7363和ST1901(国际上最常见的是NG-MAST ST1407),它们也表现出产生高水平头孢曲松耐药性的能力(超级细菌H041和F89),可能最早在日本包括神奈川县在内的大都市地区出现、进化并开始传播,随后在全球范围内传播。